ArticleMolecules (Basel, Switzerland)2026
Boosting Hydrogen Photogeneration via Controlled CdS Nucleation on PEI-Modified Graphene Surfaces.
Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- CdS-Based Photocatalysts for Antimicrobial Applications: From Quantum Dots to Z-Scheme Heterojunctions-Mechanisms, Challenges, and Future Perspectives.Molecules (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The performance of CdS-based photocatalysts can be enhanced by incorporating graphene co-catalysts in close contact with the photoactive phase. However, assembling these distinct components remains a bottleneck, as their differing chemical natures often limit effective interfacial interaction when they are synthesized separately. In this work, we present an adaptable PEI-mediated interfacial assembly strategy for promoting the nucleation and growth of nanocrystalline CdS phases on different graphene-based supports within a common, yet support-adapted, approach. Specifically, by functionalizing the surface of various graphene materials with hyperbranched polyethyleneimine (PEI) as a multifunctional interlayer mediator, we achieve controlled CdS formation. This strategy provides a common chemical framework for producing CdS nanocrystals closely associated with the carbon surface, regardless of the substrate. Diverse materials, including low-defect graphene sheets (G-Sheets), graphene nanoplatelets (GNPs), and graphene oxide (GO), were integrated using tailored architectures: noncovalent PDI-anchoring for GNP and G-Sheets and direct covalent functionalization for GO. In the latter case, PEI acts simultaneously as a mild reducing agent, yielding a covalently grafted reduced graphene oxide hybrid (rGO-PEI). XRD patterns confirm comparable CdS crystallinity across all hybrids, while photocatalytic hydrogen evolution measurements reveal a strong dependence on the nature of the graphene support. rGO-PEI@CdS exhibits the highest hydrogen evolution rate (0.44 mmol g
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.